The invention discloses schisandra liver-benefiting capsules, which relates to a Chinese patent medicament, in particular to a capsule preparation for oral administration for treating hepatitis B virus carriers and hepatitis symptoms caused by the hepatitis B virus carriers such as jaundice and transaminase rise. The invention provides the capsule preparation for bilirubin caused by the hepatitisB virus carriers. The capsule preparation for bilirubin abnormality, glutamic-pyruvic transaminase abnormality, glutamic-oxalacetic transaminase abnormality and r-glutamyl transpeptidase abnormality caused by the hepatitis B virus carriers has the characteristics of low treatment cost, low dose, no toxic or side effect and quick enzyme drop, has high negative conversion ratio of hepatitis B virus, and has no phenomena of rebound, medicament resistance and virus variation after medicament stop. The schisandra liver-benefiting capsules have the effects of removing dampness and relieving toxin, inhibiting and clearing the hepatitis B virus, soothing the liver and breaking blood stasis, promoting qi circulation and relieving depression, tonifying spleen and removing retention, tonifying qi, warming channels, stimulating qi and blood and strengthening the body resistance to eliminate pathogenic factors by using the traditional Chinese medicament theory. The schisandra liver-benefiting capsules have the advantages of accurate curative effect, convenient administration, safety and reliability.